{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T23:18:33Z","timestamp":1761952713946,"version":"build-2065373602"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Electrocardiology"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1016\/j.jelectrocard.2007.09.010","type":"journal-article","created":{"date-parts":[[2008,3,11]],"date-time":"2008-03-11T09:17:11Z","timestamp":1205227031000},"page":"102-106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Coexistent manifestations of the Andersen-Tawil and Brugada syndromes"],"prefix":"10.1016","volume":"41","author":[{"given":"Adrian H.","family":"Shandling","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Safani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jelectrocard.2007.09.010_bib1","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0092-8674(01)00342-7","article-title":"Mutations in Kir 2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome","volume":"105","author":"Plaster","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.jelectrocard.2007.09.010_bib2","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1172\/JCI15183","article-title":"Functional and clinical characterization of KCNJ2 mutations associated with LQTS (Andersen syndrome)","volume":"110","author":"Tristani-Firouzi","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jelectrocard.2007.09.010_bib3","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1161\/CIRCULATIONAHA.104.472498","article-title":"Electrocardiographic features in Andersen-Tawil Syndrome patients with KCNJ2 mutations: characteristic T-U-wave patterns predict the KCNJ2 genotype","volume":"111","author":"Zhang","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jelectrocard.2007.09.010_bib4","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0022-2828(03)00046-4","article-title":"Function, subcellular localization and assembly of a novel mutation of KCNJ2 in Andersen's syndrome","volume":"35","author":"Hosaka","year":"2003","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jelectrocard.2007.09.010_bib5","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/0735-1097(92)90253-J","article-title":"Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome","volume":"20","author":"Brugada","year":"1992","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jelectrocard.2007.09.010_bib6","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0735-1097(02)01962-9","article-title":"Genotype-phenotype relationship in Brugada syndrome: electrocardiographic features differentiate SCN5A-related patients from non\u2013SCN5A-related patients","volume":"40","author":"Smits","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jelectrocard.2007.09.010_bib7","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1111\/j.1540-8159.2006.00507.x","article-title":"Brugada syndrome","volume":"29","author":"Antzelevitch","year":"2006","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jelectrocard.2007.09.010_bib8","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0735-1097(01)01421-8","article-title":"The prevalence, incidence and prognostic value of the Brugada-type electrocardiogram. A population-based study of four decades","volume":"38","author":"Matsuo","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jelectrocard.2007.09.010_bib9","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1161\/hc0602.103618","article-title":"Clinical and molecular heterogeneity in the Brugada syndrome: a novel gene locus chromosome 3","volume":"105","author":"Weiss","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jelectrocard.2007.09.010_bib10","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/j.hrthm.2006.02.112","article-title":"A mutation in the glycerol-3-phosphate dehydrogenase 1\u2013like gene (GPD1L) causes Brugada syndrome","volume":"3","author":"London","year":"2006","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jelectrocard.2007.09.010_bib11","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1161\/01.CIR.0000034169.45752.4A","article-title":"Proposed diagnostic criteria for the Brugada syndrome: consensus report","volume":"106","author":"Wilde","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jelectrocard.2007.09.010_bib12","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1161\/01.CIR.0000152479.54298.51","article-title":"Brugada syndrome: report of the Second Consensus Conference","volume":"111","author":"Antzelevitch","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jelectrocard.2007.09.010_bib13","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/j.jacc.2003.07.005","article-title":"QT-interval prolongation in right precordial leads: an additional electrocardiographic hallmark of Brugada syndrome","volume":"42","author":"Pitzalis","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jelectrocard.2007.09.010_bib14","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1161\/01.CIR.0000153267.21278.8D","article-title":"Long-term prognosis of individuals with right precordial ST-segment-elevation Brugada syndrome","volume":"111","author":"Eckardt","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jelectrocard.2007.09.010_bib15","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.jacc.2003.06.004","article-title":"Ventricular arrhythmias induced by sodium channel blockers in patients with Brugada syndrome","volume":"42","author":"Morita","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jelectrocard.2007.09.010_bib16","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1161\/01.CIR.0000143159.30585.90","article-title":"Efficacy of quinidine in high-risk patients with Brugada syndrome","volume":"110","author":"Belhassen","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jelectrocard.2007.09.010_bib17","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1111\/j.1540-8167.1999.tb00183.x","article-title":"Effects of electrophysiologic-guided therapy with class IA anti-arrhythmic drugs on the long-term outcome of patients with idiopathic ventricular fibrillation with or without the Brugada syndrome","author":"Belhassen","year":"1999","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jelectrocard.2007.09.010_bib18","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1053\/euhj.2001.2824","article-title":"Task force on sudden cardiac death of the European Society of Cardiology","volume":"22","author":"Priori","year":"2001","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jelectrocard.2007.09.010_bib19","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1161\/CIRCULATIONAHA.106.178104","article-title":"ACC\/AHA\/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death\u2014executive summary","volume":"114","author":"Zipes","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jelectrocard.2007.09.010_bib20","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.RES.85.12.1206","article-title":"A single NA+ channel mutation causing both long-QT and Brugada syndromes","volume":"85","author":"Bezzina","year":"1999","journal-title":"Circ Res"},{"key":"10.1016\/j.jelectrocard.2007.09.010_bib21","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1161\/01.CIR.102.9.945","article-title":"The elusive link between LQT3 and Brugada syndrome: the role of flecainide challenge","volume":"102","author":"Priori","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jelectrocard.2007.09.010_bib22","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/j.1552-4604.1991.tb04964.x","article-title":"Classification of the anti-arrhythmic action of moricizine","volume":"31","author":"Vaughan Williams","year":"1991","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.jelectrocard.2007.09.010_bib23","doi-asserted-by":"crossref","first-page":"27F","DOI":"10.1016\/0002-9149(87)90717-X","article-title":"Electrophysiologic aspects of moricizine HCl","volume":"60","author":"Rosenshtraukh","year":"1987","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jelectrocard.2007.09.010_bib24","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0002-8703(86)90270-X","article-title":"Ethmozine: electrophysiology, hemodynamics, and anti-arrhythmic efficacy in patients with life-threatening ventricular arrhythmias","volume":"112","author":"Dorian","year":"1986","journal-title":"AM Heart J"},{"key":"10.1016\/j.jelectrocard.2007.09.010_bib25","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.hrthm.2006.12.031","article-title":"Flecainide for recurrent malignant ventricular arrhythmias in two siblings with Anderson-Tawil syndrome","volume":"4","author":"Bokenkamp","year":"2007","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jelectrocard.2007.09.010_bib26","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1212\/WNL.59.3.466","article-title":"Amiodarone and acetazolamide for the treatment of genetically confirmed severe Andersen syndrome","volume":"59","author":"Junker","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.jelectrocard.2007.09.010_bib27","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1161\/01.CIR.0000088781.99943.95","article-title":"Mapping and ablation of ventricular fibrillation associated with long-QT and Brugada syndromes","volume":"108","author":"Haissaguerre","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jelectrocard.2007.09.010_bib28","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1161\/CIRCULATIONAHA.106.668392","article-title":"Loss-of-function mutations in cardiac calcium channel underlie a new clinical entity characterized by ST segment elevation, short QT intervals, and sudden cardiac death","volume":"115","author":"Antzelevitch","year":"2007","journal-title":"Circulation"}],"container-title":["Journal of Electrocardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022073607008692?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022073607008692?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T12:18:20Z","timestamp":1758284300000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022073607008692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S0022073607008692"],"URL":"https:\/\/doi.org\/10.1016\/j.jelectrocard.2007.09.010","relation":{},"ISSN":["0022-0736"],"issn-type":[{"type":"print","value":"0022-0736"}],"subject":[],"published":{"date-parts":[[2008,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coexistent manifestations of the Andersen-Tawil and Brugada syndromes","name":"articletitle","label":"Article Title"},{"value":"Journal of Electrocardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jelectrocard.2007.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}